Sign up to save your podcasts
Or
Share JOQ S3 E6: Biotech expert Seth and Nick discuss revolutionary regenerative medicine treatments
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JOQ S3 E6: Biotech expert Seth and Nick discuss revolutionary regenerative medicine treatments
Seth Ettenberg and Nick discuss how technology is used to develop regenerative medicine for conditions such as Parkinson's disease and Alzheimer's disease.
Seth Ettenberg is CEO and President of BlueRock Therapeutics, a wholly owned subsidiary of Bayer. He’s a biotech entrepreneur, on the cutting edge of something called regenerative medicine.
View all episodes
By Nick MorganSeth Ettenberg and Nick discuss how technology is used to develop regenerative medicine for conditions such as Parkinson's disease and Alzheimer's disease.
Seth Ettenberg is CEO and President of BlueRock Therapeutics, a wholly owned subsidiary of Bayer. He’s a biotech entrepreneur, on the cutting edge of something called regenerative medicine.